IQV Long Put Strategy
IQV (IQVIA Holdings Inc.), in the Healthcare sector, (Medical - Diagnostics & Research industry), listed on NYSE.
IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services.
IQV (IQVIA Holdings Inc.) trades in the Healthcare sector, specifically Medical - Diagnostics & Research, with a market capitalization of approximately $31.90B, a trailing P/E of 23.24, a beta of 1.22 versus the broader market, a 52-week range of 154.5-247.05, average daily share volume of 1.7M, a public-listing history dating back to 2013, approximately 89K full-time employees. These structural characteristics shape how IQV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.22 places IQV roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a long put on IQV?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current IQV snapshot
As of June 30, 2026, spot at $193.65, ATM IV 39.90%, IV rank 41.40%, expected move 11.44%. The long put on IQV below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this long put structure on IQV specifically: IQV IV at 39.90% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 11.44% (roughly $22.15 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated IQV expiries trade a higher absolute premium for lower per-day decay. Position sizing on IQV should anchor to the underlying notional of $193.65 per share and to the trader's directional view on IQV stock.
IQV long put setup
The IQV long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With IQV near $193.65, the first option leg uses a $195.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed IQV chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 IQV shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $195.00 | $7.25 |
IQV long put risk and reward
- Net Premium / Debit
- -$725.00
- Max Profit (per contract)
- $18,774.00
- Max Loss (per contract)
- -$725.00
- Breakeven(s)
- $187.75
- Risk / Reward Ratio
- 25.895
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
IQV long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on IQV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$18,774.00 |
| $42.83 | -77.9% | +$14,492.40 |
| $85.64 | -55.8% | +$10,210.80 |
| $128.46 | -33.7% | +$5,929.21 |
| $171.27 | -11.6% | +$1,647.61 |
| $214.09 | +10.6% | -$725.00 |
| $256.91 | +32.7% | -$725.00 |
| $299.72 | +54.8% | -$725.00 |
| $342.54 | +76.9% | -$725.00 |
| $385.35 | +99.0% | -$725.00 |
When traders use long put on IQV
Long puts on IQV hedge an existing long IQV stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying IQV exposure being hedged.
IQV thesis for this long put
The market-implied 1-standard-deviation range for IQV extends from approximately $171.50 on the downside to $215.80 on the upside. A IQV long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long IQV position with one put per 100 shares held. Current IQV IV rank near 41.40% is mid-range against its 1-year distribution, so the IV signal is neutral; the long put thesis on IQV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, IQV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to IQV-specific events.
IQV long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. IQV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move IQV alongside the broader basket even when IQV-specific fundamentals are unchanged. Long-premium structures like a long put on IQV are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current IQV chain quotes before placing a trade.
Frequently asked questions
- What is a long put on IQV?
- A long put on IQV is the long put strategy applied to IQV (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With IQV stock trading near $193.65, the strikes shown on this page are snapped to the nearest listed IQV chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are IQV long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the IQV long put priced from the end-of-day chain at a 30-day expiry (ATM IV 39.90%), the computed maximum profit is $18,774.00 per contract and the computed maximum loss is -$725.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a IQV long put?
- The breakeven for the IQV long put priced on this page is roughly $187.75 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current IQV market-implied 1-standard-deviation expected move is approximately 11.44%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on IQV?
- Long puts on IQV hedge an existing long IQV stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying IQV exposure being hedged.
- How does current IQV implied volatility affect this long put?
- IQV ATM IV is at 39.90% with IV rank near 41.40%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.